Concepedia

Sophia Gayle

SG

Statistics

Publications

8

Citations

376

H-Index

8

Active since

2011

Affiliations

Yale University(Current)

Howard Hughes Medical Institute

Sophia Gayle is an author at Yale University specializing in oncology, targeted therapy, and pharmacology.

ORCID

Publications per year

2011–2022

8

Publications

8

Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma

Sophia Gayle, Sean F. Landrette, Neil Beeharry et al. · Blood · 2017 · 206 citations · Full text

, , +14

TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor

Ukhyun Jo, Yasuhisa Murai, Keli Agama et al. · Molecular Cancer Therapeutics · 2022 · 53 citations · Full text

, , +16

Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity

Sophia Gayle, Robert J. Aiello, Nalin Leelatian et al. · NAR Cancer · 2021 · 30 citations · Full text

, , +17

Loss of <i>Drosophila melanogaster p21-activated kinase 3</i> Suppresses Defects in Synapse Structure and Function Caused by <i>spastin</i> Mutations

Emily F. Ozdowski, Sophia Gayle, Hong Bao et al. · Genetics · 2011 · 24 citations · Full text

, , +17

B-cell non-Hodgkin lymphoma: Selective vulnerability to PIKFYVE inhibition

Sophia Gayle, Sean F. Landrette, Neil Beeharry et al. · Autophagy · 2017 · 22 citations · Full text

, , +17

1–5 of 8